In the present study, we identify intrinsic cardiac adrenergic (ICA) cells in the neonatal rat heart using immunofluorescent histochemical staining techniques with antibodies that specifically recognize the major enzymes in the catecholamine biosynthetic pathway. ICA cells are most concentrated near the endocardial surface of ventricular myocardium, but are also found sporadically throughout the heart. In primary cultures of neonatal rat cardiomyocytes, ICA cells are closely associated with clusters of cardiomyocytes. To investigate a potential role for intrinsically produced catecholamines, we recorded beating rates in the presence and absence of the catecholamine-depleting agent reserpine or the adrenergic receptor blockers prazosin and timolol using videomicroscopy and photodiode sensors. Our results show that beating rates slow significantly when endogenous catecholamines are depleted or when their action is blocked with either a ␤-or an ␣ 1 -adrenergic receptor antagonist. These data indicate that intrinsic cardiac catecholamines help to maintain beating rates in neonatal rat cardiomyocyte cultures via stimulation of ␣ 1 -and ␤-adrenergic receptors. This information should help to increase our understanding of the physiologic mechanisms governing cardiovascular function in neonates. The catecholamines epinephrine and norepinephrine are neurotransmitter stress hormones that influence cardiac function profoundly. We and others have shown that the heart itself produces these catecholamines in specialized cells known as ICA cells (1-3). We have also shown that these cells are transiently and progressively associated with different regions of the embryonic rat heart that are important sites for pacemaking and conduction tissue development (e.g. sinoatrial node, atrioventricular canal, bundle of His, and ventricular septum) (3). ICA cells appear to persist in the heart postnatally as they have been found in neonatal (1, 4 -6) and adult (1, 7-11) hearts. In adult hearts, ICA cells are often found clustered around sites of innervation (6, 7, 10). In the neonate, sympathetic innervation of the heart is incomplete (12), and little is known about the specific distribution of ICA cells in the heart (13-15). Further, the functional significance of these ICA cells in the neonatal (or adult) heart is unknown.
In the present study, we identify intrinsic cardiac adrenergic (ICA) cells in the neonatal rat heart using immunofluorescent histochemical staining techniques with antibodies that specifically recognize the major enzymes in the catecholamine biosynthetic pathway. ICA cells are most concentrated near the endocardial surface of ventricular myocardium, but are also found sporadically throughout the heart. In primary cultures of neonatal rat cardiomyocytes, ICA cells are closely associated with clusters of cardiomyocytes. To investigate a potential role for intrinsically produced catecholamines, we recorded beating rates in the presence and absence of the catecholamine-depleting agent reserpine or the adrenergic receptor blockers prazosin and timolol using videomicroscopy and photodiode sensors. Our results show that beating rates slow significantly when endogenous catecholamines are depleted or when their action is blocked with either a ␤-or an ␣ 1 -adrenergic receptor antagonist. These data indicate that intrinsic cardiac catecholamines help to maintain beating rates in neonatal rat cardiomyocyte cultures via stimulation of ␣ 1 -and ␤-adrenergic receptors. This information should help to increase our understanding of the physiologic mechanisms governing cardiovascular function in neonates. The catecholamines epinephrine and norepinephrine are neurotransmitter stress hormones that influence cardiac function profoundly. We and others have shown that the heart itself produces these catecholamines in specialized cells known as ICA cells (1) (2) (3) . We have also shown that these cells are transiently and progressively associated with different regions of the embryonic rat heart that are important sites for pacemaking and conduction tissue development (e.g. sinoatrial node, atrioventricular canal, bundle of His, and ventricular septum) (3) . ICA cells appear to persist in the heart postnatally as they have been found in neonatal (1, 4 -6) and adult (1, (7) (8) (9) (10) (11) hearts. In adult hearts, ICA cells are often found clustered around sites of innervation (6, 7, 10) . In the neonate, sympathetic innervation of the heart is incomplete (12) , and little is known about the specific distribution of ICA cells in the heart (13) (14) (15) . Further, the functional significance of these ICA cells in the neonatal (or adult) heart is unknown.
The neonatal period is characterized by dramatic cardiovascular adaptation to extrauterine life. Although peripheral catecholamines are synthesized by the adrenal medulla (16 -18) and organ of Zuckerkandl (19, 20) in the perinatal period, functional sympathetic innervation of the heart is not completed until the second week after birth in rats (15, 21) . The neonatal rat heart, nevertheless, expresses fully functional ␣-and ␤-adrenergic receptors, allowing for chronotropic responses to either ␣ 1 -or ␤-adrenergic agonists (22) (23) (24) . Once functional sympathetic innervation of the heart is achieved, ␣ 1 -agonists lose their ability to stimulate heart rate (22) , which comes increasingly under ␤-adrenergic control, as seen in the adult (25, 26) . Well before such innervation-dependent changes happen, however, chronotropic responses to exogenously administered catecholamines occur (27) (28) (29) (30) (31) . The source(s) of endogenous catecholamines that regulate heart rate during perinatal development remain undefined.
In the present study, we used immunofluorescence histochemical and cytochemical staining techniques to demonstrate the presence of ICA cells in neonatal rat hearts and primary cultures of cardiomyocytes isolated from neonatal rat hearts by their ability to express catecholamine biosynthetic enzymes. We also used pharmacological interventions to demonstrate possible roles for these locally produced catecholamines during cardiac development by evaluating beating rate responses in primary cultures of neonatal rat cardiomyocytes using videomicroscopy, photodiode sensors, and customized data acquisition/analysis software.
METHODS

Materials.
All drugs and chemicals used for this study were purchased from Sigma Chemical (St. Louis, MO, U.S.A.). Drugs were prepared as concentrated stock solutions and frozen in small aliquots at Ϫ80°C. The stock aliquots were thawed immediately before use and were not refrozen. Rabbit anti-PNMT and anti-DBH antisera have been previously described (3). Mouse monoclonal anti-TH and anti-sarcomeric ␣-actinin antibodies were purchased from Sigma Chemical. FITC-conjugated donkey anti-rabbit and TRITC-conjugated donkey anti-mouse secondary antibodies were obtained from Jackson Immunoresearch (West Grove, PA, U.S.A.).
Animals. Timed-pregnant Sprague-Dawley rats were obtained from Taconic Farms (Germantown, NY, U.S.A.). Neonatal pups were used within the first 2 d after birth. All experiments were conducted in strict concordance with the guidelines provided by the Georgetown University Animal Care and Use Committee and the National Institutes of Health.
Immunofluorescent histochemical and cytochemical staining. Double immunofluorescent staining of neonatal rat hearts and cardiomyocyte cultures was performed essentially as described previously (3) . For immunofluorescent cytochemical staining of cultured cardiomyocytes, the myocytes were seeded onto collagen-coated coverslips (12 mm round) at the time of isolation, and allowed to grow in culture for 7-9 d before fixation. To fix the cells, the culture medium was removed and the cells were rinsed twice with PBS. The cells were then exposed to 4% paraformaldehyde in PBS for 15 min at room temperature. At the end of this fixation period, the fixative was removed and the cells were washed twice with PBS. The cells were then used immediately for immunofluorescent staining or stored in PBS at 4°C for subsequent staining.
Because the anti-DBH and anti-PNMT antisera were produced in rabbits while the anti-TH antibody was produced in mice, FITC-conjugated anti-rabbit (green fluorescence) and TRITC-conjugated anti-mouse (red fluorescence) secondary antibodies were used to detect specific labeling of DBH-(or PNMT-) and TH-expressing cells, respectively. We have previously demonstrated the specificity of these antibodies using immunofluorescent histochemical staining assays (3) .
Preparation of rat neonatal cardiomyocyte cultures. Neonatal rat cardiomyocytes were prepared according to Simpson and Savion (32) , with the following modifications: Neonatal rat pups were killed by swift decapitation within the first 2 d after birth. The heart was immediately removed under aseptic conditions and placed in ice-cold sterile HBSS (no Ca ϩϩ or Mg ϩϩ ). Enzymatic and mechanical dissociation of cardiomyocytes was then performed using the Neonatal Cardiomyocyte Isolation System supplied by Worthington Biochemicals (Freehold, NJ, U.S.A.). The hearts were minced on ice and digested overnight at 4°C with purified trypsin (10 g/mL) in HBSS. On the following morning, the digested tissue was transferred to a 50-mL conical tube and purified soybean trypsin inhibitor (40 g/mL) was added to terminate trypsinization. The tissue was oxygenated and warmed to 37°C. Purified collagenase (10 U/mL) was added and digestion proceeded for 45 min at 37°C with intermittent gentle swirling. Mild trituration was then used to mechanically dissociate the digested tissue, and singlecell suspensions were obtained by filtering this digested material through 70 m sterile mesh filters. The cells were collected by low-speed centrifugation. The supernatant was discarded and the cell pellet resuspended in DMEM (high glucose, Biofluids, Rockville, MD, U.S.A.) culture medium containing 10% defined iron-supplemented bovine calf serum (Hyclone Laboratories, Logan, UT, U.S.A.), 2 mM glutamine, and gentamicin sulfate (50 g/mL). In some experiments, the serum was pretreated with charcoal before adding it to the media (10% volume as above) to remove possible trace amounts of catecholamines that may have been present. The cells were then "preplated" to remove fibroblasts as described previously (7), and the remaining cells counted and seeded onto multiwell culture plates at a density of 75,000 cells per cm 2 . The media was changed every 2-3 d beginning the day after seeding. Bromodeoxyuridine (0.1 mM) was added to the culture media for the first 3 d to further minimize contamination from fibroblasts (32) .
Beating rate measurements. Beating activity of cultured cardiomyocytes was measured by edge-detection using photodiode sensors attached to a monitor screen depicting beating cells viewed by videomicroscopy. The entire microscope was enclosed in a temperature-controlled (37°C), custom-designed incubation chamber (Part numbers: 8400 -005, 8506 -050, and 8537-025; Coy Laboratory Products, Inc., Grass Lake, MI, U.S.A.) fed with 5% CO 2 /95% air to maintain constant pH. The photodiode sensor signal was filtered with an 8-pole Bessel low-pass filter (Model 900CT, Frequency Devices, Inc., Havervill, MA, U.S.A.) with a cutoff frequency of 1000 Hz, and relayed to a PC equipped with a National Instruments data acquisition board and LabView 4.0 processing software. Parallel outputs were also directed to a Gould TA550 chart recorder and an oscilloscope. Data were continuously acquired and stored to disk for later analysis. Drugs were added and immediately mixed in the media overlying the cells in each well. Predrug (baseline) measurements were performed first, and the indicated drug(s) were added as a 100ϫ stock to the preexisting media on each well, and rapidly mixed. Beating rates were remeasured within 2-3 min after drug addition.
Data analysis. The number of beating rate measurements was typically obtained from different wells of multi-well plates (usually six wells per plate) seeded from the same preparation of myocytes. Measurements were obtained immediately before and after the addition of specified drugs. In the reserpine experiment, beating rate measurements were obtained at mul-412 tiple time-points after drug administration. Each experiment was replicated at least twice using independently isolated cultures, and a representative result from each is shown. Unless otherwise indicated, all beating rate measurements were performed on cells that had been cultured for 7-9 d. All data are expressed as mean Ϯ SEM. Statistical significance was assessed by one-way ANOVA, with p Ͻ 0.05 required to reject the null hypothesis. Posthoc testing was performed using Bonferroni's correction for multiple comparisons.
RESULTS
To identify ICA cells in neonatal rat hearts, we used immunofluorescent histochemical staining techniques using antibodies that specifically recognize the major catecholamine biosynthetic enzymes. Many brightly labeled fluorescent cells were identified using anti-PNMT antiserum (Fig. 1, A and C, arrows) . Co-staining with an anti-TH antibody revealed an essentially identical pattern of expression (Fig. 1, B and D, arrows; compare with A and C, respectively). These ICA cells were primarily found in the ventricular myocardium near the endocardial surface, but were also observed sporadically throughout the heart. For anatomical reference, the ventricular lumen (VL) is indicated ( Figs. 1 and 2) . A similar pattern of co-staining was observed when we used anti-DBH and anti-TH antibodies (Fig. 2) . Positively labeled cells appeared bright, were roundish or triangular in shape, and primarily displayed cytoplasmic staining patterns. This was most evident at higher magnification (Figs. 1 and 2, panels C and D). Thus, each of the three independent catecholamine biosynthetic enzyme (TH, DBH, and PNMT) antibodies selectively labeled a highly similar subset of cardiac cells in neonatal rat hearts.
To view these presumptive ICA cells in relation to cardiomyocytes, we co-stained sections for PNMT and a myocytespecific marker, sarcomeric ␣-actinin. As shown in Figure 3A , individual ICA cells were again identified in ventricular myo- cardium. When co-stained for ␣-actinin, a characteristic ladder-like sarcomeric pattern was evident in many myocytes (Fig. 3B) . By superimposing the PNMT and ␣-actinin images, we obtained an "overlay" image where ICA cells can be visualized in direct juxtaposition to underlying myocytes (Fig.  3C) .
To identify ICA cells in primary cultures of neonatal rat cardiomyocytes, we seeded the cardiomyocytes onto collagencoated coverslips and allowed them to develop into synchronous rhythmic beating clusters of cardiomyocytes over a 7-d period. The cells were then fixed and co-immunofluorescently labeled for PNMT and sarcomeric ␣-actinin (Fig. 3, D and E,  respectively) . PNMT staining was punctate and cytoplasmic, whereas ␣-actinin staining was evident in sarcomeric structures (Fig. 3E) . The overlay image shown in Figure 3F clearly shows an ICA cell sitting atop a cluster of cardiomyocytes. ICA cells could also be identified in these cultures by co-staining for DBH and TH (not shown). Although the relative abundance of ICA cells in these neonatal rat cardiomyocyte cultures was low (only ‫1ف‬ ICA cell/2 ϫ 10 5 myocytes), these results nevertheless show that ICA cells were present and that they were closely associated with cardiomyocyte clusters.
To determine whether beating activity in culture was dependent upon local catecholamine production, the wells were treated with increasing concentrations of reserpine, a catecholamine-depleting agent. Significant dose-dependent decreases in beating rates were observed in the presence of reserpine (Fig. 4, A and B) . These decreases could be largely reversed by the addition of norepinephrine (Fig. 4C) . These results suggest that endogenous catecholamines are needed for the maintenance of beating rates in these cardiomyocyte cultures.
Consistent with this idea, acute treatment of spontaneously beating myocyte cultures with either the ␣ 1 -selective antagonist, prazosin, or the ␤-selective antagonist, timolol, led to dose-dependent decreases in the beating rate within seconds after drug application (Fig. 5 ). Significant slowing ‫%52ف(‬ decrease) in the beating rate was observed in the presence of 1 M prazosin (p Ͻ 0.01, n ϭ 10). When the prazosin concentration was increased to 10 M, severe depression (Ͼ85% decrease) in the beating rate occurred. Timolol also caused significant concentration-dependent slowing in the beating rate (p Ͻ 0.01, n ϭ 6). These results show that application of either ␣ 1 -or ␤-adrenergic receptor blockers lead to concentrationdependent slowing of beating rate.
To test the possibility that serum catecholamines may have influenced our results, we stripped the serum using charcoaltreatment to remove any trace amounts of catecholamines that may have been present. Beating activity was maintained for at least 72 h after charcoal-stripping (Fig. 6) . The ␤-blocker timolol strongly suppressed beating activity under these conditions, an effect that was fully rescued by the addition of epinephrine (Fig. 6) . Similarly, application of the ␣ 1 -blocker prazosin led to significant decreases in beating rates (Fig. 7) . The addition of the ␣ 1 -selective agonist, L-phenylephrine, resulted in a dose-dependent reversal of the prazosin-induced decrease in beating rate. These results show that ␣ 1 -and ␤-adrenergic receptor antagonists were effective at blocking beating even in the absence of any potential influence from serum catecholamines.
DISCUSSION
The results presented in this study indicate that intrinsic cardiac catecholamines play an important role in helping to maintain beating rates of cultured neonatal rat cardiomyocytes. The evidence supporting this claim is summarized as follows: i) using immunofluorescent staining techniques, ICA cells were found to be present in close association with cardiomyocytes both in vivo and in vitro; ii) depletion of endogenous catecholamines by treatment with reserpine led to significant decreases in beating rate that were subsequently recovered by the addition of norepinephrine; iii) blockade of either ␣ 1 -or ␤-adrenergic receptors led to concentration-dependent decreases in beating rates that could be "rescued" by the addition of adrenergic agonists; and iv) elimination of potential trace amounts of catecholamines from the serum used for culturing the cardiomyocytes did not prevent either the ␤-antagonist, timolol, or the ␣ 1 -antagonist, prazosin, from causing significant decreases in the beating rate. Although it has been known for many years that exogenous catecholamines can influence cardiovascular function (27, 33, 34) , this is the first report to systematically demonstrate that endogenous cardiac catecholamines, acting through ␣ 1 -and ␤-adrenergic receptors, are necessary for the maintenance of beating activity in neonatal cardiomyocyte cultures.
As shown in the present report, the adrenergic antagonists used in this study were effective at slowing "spontaneous" beating rates even when charcoal-stripped serum, free of catecholamines, was used. In general, serum was included in our media because the cells appeared healthier and beating activity was more stable when serum (nonstripped) was used as a media supplement. When charcoal-stripped or serum-free media was used, the concentrations of the antagonists or reserpine required to inhibit beating activity was much less than that needed in the presence of untreated serum. This difference in drug sensitivity may reflect a decrease in nonspecific drug binding by serum proteins, and, hence, lower concentrations of the drugs were needed to produce the same effect as when nonstripped serum was used. It is also possible that other small molecules and growth factors removed by the charcoalstripping procedure could have rendered the cells more sensitive to drugs that deplete or block catecholamine actions. We submit, however, that the possibility that the serum was a significant source of catecholamines is highly unlikely because we found no measurable amounts of either epinephrine or norepinephrine using a sensitive RIA (lower limit of assay sensitivity ‫4ف‬ pg/mg total protein/mL) (3). We also performed additional experiments using defined, serum-free media (22, 35) where we found that reserpine (1 M) was still effective at blocking beating activity (data not shown). As was the case when serum was included (Fig. 4) , the cessation of beating activity in the presence of reserpine could be recovered by the addition of epinephrine or norepinephrine. Taken together, these results suggest that intrinsically produced catecholamines function to regulate beating activity in cardiomyocyte cultures 
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tend to be rectangular in appearance, ICA cells were somewhat roundish or triangular in shape, consistent with previous findings (1) .
Neonatal rat cardiomyocyte cultures are a well-established model for studying the functional development of cardiac beating activity (32, 35) , and early studies have shown that either ␣ 1 -or ␤-agonists could stimulate beating activity in these cultures (22) . Once sympathetic innervation is achieved, the chronotropic effects of ␣ 1 -agonists subside in favor of the more adult-like ␤-adrenergic-mediated control of heart rate (24) . During the early neonatal period, however, there is minimal sympathetic nerve influence. Intrinsic cardiac adrenergic cells may, therefore, play a more prominent role in the heart during this early postnatal period of development.
High demands are placed on cardiovascular function as newborns adapt to extrauterine life. Having a local source of catecholamines within the heart may enhance cardiovascular function, though this may not be absolutely necessary for survival because certain mice and humans who lack the ability to produce norepinephrine and epinephrine due to a genetic disruption of the gene encoding DBH have survived past the early postnatal period (36, 37) . In mice, most dbh Ϫ/Ϫ embryos die from cardiovascular failure in utero, but can be "rescued" by administration of DOPS in the maternal drinking water (37) . DOPS is a synthetic compound that can be converted into norepinephrine in vivo via a DBH-independent mechanism. Once born, some DOPS-rescued dbh Ϫ/Ϫ embryos are then able to survive without further drug interventions, though it is unclear how much DOPS and norepinephrine/epinephrine may persist after birth in the neonate. Nevertheless, it is clear that norepinephrine and/or epinephrine are important for postnatal survival since "about 40% of the mutant (dbh Ϫ/Ϫ ) mice born die within several days of birth and another 20% die during the third, fourth, and fifth postnatal weeks" (38) .
What are the source(s) of endogenous catecholamines? We have shown that neonatal rat cardiomyocyte cultures have the capacity to synthesize catecholamines. Further, we demonstrated a possible role for intrinsic cardiac catecholamines in regulating beating rates. These findings are consistent with the idea proposed by Hsu (34) more than 70 y ago when he noted strong cardiac responses upon applying epinephrine or acetylcholine to embryonic chick hearts: "Should it be possible, however, to detect the presence of acetylcholine and adrenaline in the embryo of the age we have worked with, our result would indicate a possible humoral control of heart rate before the inception of nervous control." Thus, our results suggest that ICA cells serve as an important "humoral" source of adrenergic . Effect of ␤-adrenergic blockade on beating rates in neonatal rat cardiomyocytes cultured using media containing charcoal-stripped serum. Neonatal rat cardiomyocytes were allowed to develop spontaneous beating activity under normal growth conditions for a period of 7 d. On d 7, the culture media was replaced with media containing charcoal-stripped serum to remove any residual catecholamines that may have been present in the serum. Timolol (10 M) was added to the culture medium containing the charcoal-stripped serum on half of the cultures at the time of media change on d 7. Beating rates were then assessed at 24 and 72 h after drug treatment (cells were cultured in the continuous presence of timolol). Addition of epinephrine (1 M) enabled full recovery of beating rate for at least 30 -60 min. ***p Ͻ 0.001 relative to control (n ϭ 6/group).
Figure 7.
Effect of ␣ 1 -adrenergic blockade on the beating rates in neonatal rat cardiomyocytes cultured in media containing charcoal-stripped serum. Application of the ␣ 1 -antagonist, prazosin (1 M) resulted in a significant reduction in the beating rate compared with baseline control. This reduction in the beating rate was reversed by the addition of the ␣ 1 -agonist, L-phenylephrine (L-PE) at the indicated concentrations. **p Ͻ 0.01; ***p Ͻ 0.001 (n ϭ 12/group).
